News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,172 Results
Type
Article (43060)
Company Profile (304)
Press Release (692790)
Multimedia
Podcasts (91)
Webinars (22)
Section
Business (207666)
Career Advice (2051)
Deals (35823)
Drug Delivery (122)
Drug Development (82111)
Employer Resources (174)
FDA (16518)
Job Trends (15093)
News (350470)
Policy (32909)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2661)
Academic (1)
Accelerated approval (42)
Adcomms (25)
Allergies (162)
Alliances (50877)
ALS (195)
Alzheimer's disease (1759)
Antibody-drug conjugate (ADC) (373)
Approvals (16830)
Artificial intelligence (633)
Autoimmune disease (226)
Automation (51)
Bankruptcy (363)
Best Places to Work (11718)
BIOSECURE Act (21)
Biosimilars (201)
Biotechnology (202)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (688)
Cancer (5345)
Cardiovascular disease (444)
Career advice (1738)
Career pathing (40)
CAR-T (299)
CDC (53)
Celiac Disease (2)
Cell therapy (800)
Cervical cancer (41)
Clinical research (70689)
Collaboration (1948)
Company closure (4)
Compensation (1273)
Complete response letters (69)
COVID-19 (2741)
CRISPR (100)
C-suite (999)
Cystic fibrosis (149)
Data (7086)
Decentralized trials (3)
Denatured (31)
Depression (153)
Dermatology (57)
Diabetes (552)
Diagnostics (6864)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (318)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (267)
Earnings (91652)
Editorial (61)
Employer branding (21)
Employer resources (153)
Events (120101)
Executive appointments (1046)
FDA (19934)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1641)
Gene editing (212)
Generative AI (54)
Gene therapy (655)
GLP-1 (1029)
Government (4719)
Grass and pollen (6)
Guidances (396)
Healthcare (19084)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (274)
Immuno-oncology (80)
Indications (157)
Infectious disease (3054)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (276)
Interviews (317)
IPO (16781)
IRA (50)
Job creations (3697)
Job search strategy (1450)
JPM (60)
Kidney cancer (18)
Labor market (92)
Layoffs (561)
Leadership (34)
Legal (7994)
Liver cancer (98)
Longevity (28)
Lung cancer (714)
Lymphoma (406)
Machine learning (55)
Management (60)
Manufacturing (924)
MASH (177)
Medical device (13880)
Medtech (13957)
Mergers & acquisitions (20197)
Metabolic disorders (1415)
mRNA (177)
Multiple sclerosis (173)
NASH (17)
Neurodegenerative disease (389)
Neuropsychiatric disorders (98)
Neuroscience (3162)
Neurotech (1)
NextGen: Class of 2026 (6629)
Non-profit (4611)
Now hiring (73)
Obesity (665)
Opinion (284)
Ovarian cancer (186)
Pain (228)
Pancreatic cancer (254)
Parkinson's disease (343)
Partnered (33)
Patents (554)
Patient recruitment (594)
Peanut (60)
People (60053)
Pharmaceutical (63)
Pharmacy benefit managers (32)
Phase 1 (22107)
Phase 2 (31113)
Phase 3 (23108)
Pipeline (7134)
Policy (304)
Postmarket research (2569)
Preclinical (9456)
Press Release (69)
Prostate cancer (277)
Psychedelics (49)
Radiopharmaceuticals (307)
Rare diseases (1002)
Real estate (6058)
Recruiting (70)
Regulatory (25064)
Reports (54)
Research institute (2486)
Resumes & cover letters (353)
Rett syndrome (32)
RNA editing (18)
RSV (85)
Schizophrenia (164)
Series A (273)
Series B (203)
Service/supplier (12)
Sickle cell disease (107)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (47)
Startups (3715)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (85)
The Weekly (58)
Vaccines (1059)
Venture capital (98)
Weight loss (423)
Women's health (109)
Worklife (19)
Date
Last 7 days (642)
Last 30 days (2549)
Last 365 days (30209)
2026 (8076)
2025 (30487)
2024 (35600)
2023 (40527)
2022 (51664)
2021 (56219)
2020 (54569)
2019 (47076)
2018 (35410)
2017 (32584)
2016 (32003)
2015 (38023)
2014 (31799)
2013 (26887)
2012 (29054)
2011 (29740)
2010 (27785)
Location
Africa (755)
Alabama (92)
Alaska (7)
Arizona (333)
Arkansas (14)
Asia (40379)
Australia (6633)
California (12359)
Canada (3517)
China (1245)
Colorado (525)
Connecticut (530)
Delaware (368)
Europe (87912)
Florida (1851)
Georgia (395)
Hawaii (3)
Idaho (62)
Illinois (958)
India (81)
Indiana (562)
Iowa (22)
Japan (490)
Kansas (131)
Kentucky (46)
Louisiana (39)
Maine (73)
Maryland (1502)
Massachusetts (8872)
Michigan (347)
Minnesota (686)
Mississippi (6)
Missouri (148)
Montana (36)
Nebraska (29)
Nevada (136)
New Hampshire (82)
New Jersey (3279)
New Mexico (30)
New York (3251)
North Carolina (1561)
North Dakota (8)
Northern California (6106)
Ohio (366)
Oklahoma (22)
Oregon (41)
Pennsylvania (2488)
Puerto Rico (26)
Rhode Island (50)
South America (1128)
South Carolina (76)
South Dakota (1)
Southern California (4853)
Tennessee (201)
Texas (1933)
United States (43769)
Utah (372)
Vermont (1)
Virginia (297)
Washington D.C. (82)
Washington State (990)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
736,172 Results for "vm discovery inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VizMark Secures FDA 510k Clearance for VM1 Visual Tumor Marker, Advancing Precision in Breast Cancer Imaging
January 15, 2026
·
1 min read
Job Trends
Innovation Pressure Cooker: Tackling Drug Discovery’s Biggest Challenges
Drug discovery can be an uphill battle, especially lately given recent upheaval at the FDA and muted investment activity.
BioSpace
spoke to four industry executives about key issues facing those working in this space, starting with planning around uncertainty.
April 2, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study
October 23, 2025
·
10 min read
Press Releases
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
January 20, 2026
·
1 min read
Insights
AI Drug Discovery Platforms Face New Investor Bar
In a highly competitive space, AI platforms must now prove themselves through proprietary data, focused pipelines and clinical readouts in competitive diseases. Promises of faster, cheaper drug discovery are not enough to entice strong investor engagement.
March 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
Artificial intelligence
AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
February 11, 2026
·
8 min read
·
Annalee Armstrong
Press Releases
Model Medicines to Present Ultra-Large Virtual Screening and Agentic AI Breakthroughs at AI Convergence: Small Molecule Discovery Summit
CEO, Daniel Haders II, PhD, to address the inference throughput barrier in AI-driven drug discovery and lead a roundtable on deploying LLMs and AI agents to navigate the multi-parameter optimization challenge in small molecule drug design
March 19, 2026
·
1 min read
Press Releases
March of Dimes Awards Three Scientists Discovery Grants
March 24, 2026
·
4 min read
Press Releases
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
February 13, 2026
·
5 min read
1 of 73,618
Next
